COVID-19 vaccine | Phase-III trials for Bharat Biotech’s Covaxin sees 70-80% refusal rate from volunteers

Dr Sanjay Rai, Professor of Community Medicine at AIIMS and a principal investigator for the Covaxin trial says motivation to participate is lost as people feel that a vaccine has already been found.

Update: 2020-12-17 09:38 GMT

Linked news